Akebia Therapeutics, Inc.AKBANASDAQ
Loading
Current Ratio Over TimeCompressed
Percentile Rank15
3Y CAGR-7.4%
5Y CAGR-10.6%
Studio
Year-over-Year Change

Current ratio (current assets / current liabilities)

3Y CAGR
-7.4%/yr
vs -5.1%/yr prior
5Y CAGR
-10.6%/yr
Recent acceleration
Acceleration
-2.3pp
Decelerating
Percentile
P15
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive declineCompressed
PeriodValueYoY Change
20251.13-19.4%
20241.41+18.9%
20231.18-17.2%
20221.43+37.6%
20211.04-47.7%
20201.98+33.4%
20191.49-15.6%
20181.76-29.0%
20172.48-4.3%
20162.59-